8-K
filed September 10, 2025, 7:59 PM ET
ticker LSAK
CIK 0001041514
other material
confidence high
sentiment negative
materiality 0.65
Lesaka Technologies restates Q1-Q3 FY2025 financials due to revenue classification error
LESAKA TECHNOLOGIES INC
- Unaudited quarterly statements for Sep 30, Dec 31, 2024, and Mar 31, 2025 are restated; prior filings should no longer be relied upon.
- Revenue and cost of goods sold will increase; operating income, net loss, EPS, and cash flows are unchanged.
- Error caused by subsidiary's misinterpretation of ASC 606 for certain voucher sales; classified as agent instead of principal.
- Audit committee concluded restatement after consulting with management and KPMG; internal control evaluation ongoing.
- Company may need to restate additional periods if other agreements are re-evaluated.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001062993-25-015498
- form_type
- 8-K
- ticker
- LSAK
- cik
- 0001041514
- company_name
- LESAKA TECHNOLOGIES INC
- filed_at
- 2025-09-10T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:43.179861+00:00
- generated_at
- 2026-05-17T06:57:16.652006+00:00
- sec_items
- ["4.02", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001062993-25-015498
- json_url
- https://secwatch.observer/filing/0001062993-25-015498.json
- markdown_url
- https://secwatch.observer/filing/0001062993-25-015498.md
- text_url
- https://secwatch.observer/filing/0001062993-25-015498.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1041514/000106299325015498/0001062993-25-015498-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1041514/000106299325015498/form8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IVF
INVO Fertility restates 2025 Q1-Q3 financials; non-reliance due to accounting errors
INVO Fertility, Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Filing page
SEC filing
GWLL
Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors
GOLDENWELL BIOTECH, INC.
May 26, 2026, 8:17 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP because an invoice dated September 23, 2025, from the Company’s legal counsel in the amount of $9,840 to the Company, which covered legal services rendered to the Company between May 21, 2024 and September 23, 2025, should have been recorded in the fiscal quarters when services were performed
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon
Filing page
SEC filing
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
PreAxia restates Aug 31, 2025 financials; stock award errors, material weakness
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
April 21, 2026, 7:59 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.
Filing page
SEC filing
CNTY
Century Casinos dismisses Grant Thornton, appoints EY as new auditor; cites material weaknesses
CENTURY CASINOS INC /CO/
May 28, 2026, 4:11 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
(b) Engagement of Independent Registered Public Accounting Firm On May 22, 2026, the Audit Committee appointed Ernst & Young LLP (“EY”) as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2026.
Filing page
SEC filing
SVCO
Silvaco dismisses Baker Tilly, appoints KPMG as independent auditor
Silvaco Group, Inc.
May 27, 2026, 5:25 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
on May 27, 2026, KPMG LLP (“KPMG”) was engaged as the Company’s independent registered public accounting firm
Filing page
SEC filing
ALUR
Allurion Technologies dismisses Deloitte & Touche, appoints CBIZ; discloses material weaknesses
ALLURION TECHNOLOGIES, INC.
May 27, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
should be restated, and that such unaudited condensed financial statements should no longer be relied upon
Comparable filing
On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.